Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition (PDF) ...

Mundipharma and CorMedix have unveiled a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in ...

After Xoma Royalty went on a dealmaking spree last year, the biotech royalty aggregator is now itself being bought out by its ...

With Xtandi's growth days numbered, an unfazed Astellas expects a group of new products will more than offset the decline of ...

As Pfizer gears up to defend its patents on transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis in court this week, ...

The FDA has taken umbrage with certain Incyte promotional claims related to its chronic graft-versus-host disease (cGVHD) ...

Healthcare consumer and OTC brand company Haleon has hired Richard Manso as its new U.S. chief marketing officer. His remit ...

Travis Smith was a very serious baby. Born completely unable to hear, his mother, Sierra, struggled to see his personality ...

The FDA has doled out two manufacturing-related complete response letters (CRLs), slamming the brakes on prospective ...

In a brutal first quarter for Roche, key drugs in the company’s pharmaceutical division fall short of Wall Street ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift ...

With Regeneron poised to announce a drug pricing deal with the White House Thursday, all 17 companies targeted in a round of ...